Sentences with phrase «pharmaceutical patent licensing»

Not exact matches

He represents pharmaceutical companies both large and small on a myriad of issues, as well as several universities in both patenting and licensing to outside investors.

Five years later, Gilead became the first pharmaceutical company to sign an agreement with the newly formed Medicines Patent Pool — an organisation formed to coordinate the licensing of patent - protected medicines so that they can be produced in generic form for low income counPatent Pool — an organisation formed to coordinate the licensing of patent - protected medicines so that they can be produced in generic form for low income counpatent - protected medicines so that they can be produced in generic form for low income countries.

Coming from Georgiou's lab also helped him, he thinks, because Georgiou's work is known for having a strong therapeutic bent: With 29 issued patents, more than half licensed to pharmaceutical and biotechnology companies, Georgiou has close ties with industry.

These patents have led to a number of licenses to pharmaceutical, chemical and biotechnology companies, and a number of products that have been commercialized or are in clinical development.

This process was patented and licensed to pharmaceutical companies, which led to the development of a medicinal preparation of vitamin D2 called Viosterol (4).

Patterson Belknap represents biotechnology, pharmaceutical and healthcare companies in a broad range of patent litigation matters, including patent infringement cases, PTO trial proceedings, patent licensing.

In this case my investment thesis was that the PegIntron patented delivery method that Enzon had developed and successfully licensed to a couple of major pharmaceutical manufacturers would be adopted for other drugs and that that the existing royalty streams would grow with the success of the current drugs and the addition of new ones.

Patterson Belknap represents biotechnology, pharmaceutical and healthcare companies in a broad range of patent litigation matters, including patent infringement cases, PTO trial proceedings, patent licensing.

Patterson Belknap represents biotechnology, pharmaceutical and healthcare companies in a broad range of patent litigation matters, including patent infringement cases, PTO trial proceedings, patent licensing.

(As an aside, while NAFTA did change the compulsory licensing regime with respect to pharmaceutical patents, S. 66 (1)(a) of the patent act still allows for compulsory licensing in some situations (in theory at least, I don't know of any examples in practice).

In «EU Implementing Compulsory Drug License Regime for Exports,» Bill Heinze writes, «The European Union will allow companies in the EU to apply for a license to manufacture, without the authorization of the patent holder, pharmaceutical products for export to countries in need of medicines and facing public health prLicense Regime for Exports,» Bill Heinze writes, «The European Union will allow companies in the EU to apply for a license to manufacture, without the authorization of the patent holder, pharmaceutical products for export to countries in need of medicines and facing public health prlicense to manufacture, without the authorization of the patent holder, pharmaceutical products for export to countries in need of medicines and facing public health problems.

In addition to prosecuting patent applications on behalf of public and private institutions, biotechnology companies, and pharmaceutical companies, Dr. Rearick performs IP due diligence in a variety of in - licensing and investment contexts, with specific expertise in pharmaceuticals.

Her practice focuses on biotechnology and pharmaceutical matters, including patents, licensing, and related litigation.

Represented Johns Hopkins University and Xanthus Pharmaceuticals in Delaware Court of Chancery in a dispute over ownership of intellectual property relating to a novel method of treating autoimmune disorders, resulting in negotiation of patent license.

In addition, we are well - versed in the intellectual property issues faced by pharmaceutical companies and medical device manufacturers, and regularly advise on patent strategy, freedom to operate, opinion work, and licensing, manufacturing, and distribution agreements.

Represented Johnson & Johnson's Sequus Pharmaceuticals in an action brought against it for conversion and tortious interference of a license agreement related to patents and related patented technology regarding multi-million dollar liposome - based technology.

Patterson Belknap represents biotechnology, pharmaceutical and healthcare companies in a broad range of patent litigation matters, including patent infringement cases, PTO trial proceedings, patent licensing.